Magnesium sulfate reduces the rocuronium dose needed for satisfactory double lumen tube placement conditions in patients with myasthenia gravis
- PMID: 31472669
- PMCID: PMC6717642
- DOI: 10.1186/s12871-019-0841-4
Magnesium sulfate reduces the rocuronium dose needed for satisfactory double lumen tube placement conditions in patients with myasthenia gravis
Abstract
Background: Using a minimum dose of neuromuscular blockade (NMB) to achieve intubation condition is one of the goals in anaesthesia management of patients with myasthenia gravis (MG) for thoracoscopic (VATS) thymectomy. However, tracheal intubation with double lumen tube (DLT) could be challenging if intubation condition is not optimal. This double-blind randomised controlled study was designed to investigate whether magnesium sulfate would reduce the rocuronium dose needed for DLT intubation and improve the DLT placement condition for patients with MG who were scheduled for video-assisted thoracoscopic (VATS) thymectomy.
Methods: Recruited patients were randomly assigned to receive magnesium sulfate 60 mg.kg- 1 or normal saline (control) prior to the administration of NMB. Titrating dose of rocuronium was administered to achieve train of four (TOF) ratio less than 10% before DLT intubation. The primary outcome was the rocuronium dose required to achieve TOF ratio less than 10%. The secondary outcome was intubation condition for DLT placement.
Results: Twenty-three patients had received magnesium sulfate and 22 patients had received normal saline before rocuronium administration. The required rocuronium dose [mean (standard deviation)] were 0.10 (0.05) mg.kg- 1 and 0.28(0.17) mg.kg- 1 in patients who had magnesium sulfate and normal saline respectively(P < 0.0001). With a similar depth of neuromuscular blockade and depth of anaesthesia, 100% of patients in the magnesium sulfate group and 72.7% of patients in the control group showed excellent intubation condition (P = 0.027) respectively. The patients in both groups had similar emergence characteristics.
Conclusions: Magnesium sulfate is associated with a decrease in rocuronium requirement for an optimal DLT intubation condition in patients with MG for VATS thymectomy.
Trial registration: Clinical Trial Registry of China ( http://www.chictr.org.cn ) identifier: ChiCTR-1800017696, retrospectively registered on August 10, 2018.
Keywords: Double lumen tube; Intubation; Magnesium sulfate; Myasthenia gravis; Rocuronium.
Conflict of interest statement
The authors declare that they have no competing interests.
Similar articles
-
The effect of magnesium sulphate on intubating condition for rapid-sequence intubation: a randomized controlled trial.J Clin Anesth. 2015 Nov;27(7):595-601. doi: 10.1016/j.jclinane.2015.07.002. Epub 2015 Aug 25. J Clin Anesth. 2015. PMID: 26315876 Clinical Trial.
-
Effect of pretreatment with magnesium sulphate on the duration of intense and deep neuromuscular blockade with rocuronium: A randomised controlled trial.Eur J Anaesthesiol. 2019 Jul;36(7):502-508. doi: 10.1097/EJA.0000000000001003. Eur J Anaesthesiol. 2019. PMID: 30985540 Clinical Trial.
-
A randomised controlled trial comparing rocuronium priming, magnesium pre-treatment and a combination of the two methods.Anaesthesia. 2012 Jul;67(7):748-54. doi: 10.1111/j.1365-2044.2012.07102.x. Epub 2012 Mar 15. Anaesthesia. 2012. PMID: 22420830 Clinical Trial.
-
Failure of reversion of neuromuscular block with sugammadex in patient with myasthenia gravis: case report and brief review of literature.BMC Anesthesiol. 2019 Aug 17;19(1):160. doi: 10.1186/s12871-019-0829-0. BMC Anesthesiol. 2019. PMID: 31421671 Free PMC article. Review.
-
Reducing the dose of neuromuscular blocking agents with adjuncts: a systematic review and meta-analysis.Br J Anaesth. 2021 Mar;126(3):608-621. doi: 10.1016/j.bja.2020.09.048. Epub 2020 Nov 17. Br J Anaesth. 2021. PMID: 33218672 Free PMC article.
References
Publication types
MeSH terms
Substances
Associated data
LinkOut - more resources
Full Text Sources